Bharat Biotech concludes clinical trials of intranasal COVID-19 vaccine; Says it is safe and immunogenic The vaccine maker claims that BBV154 has the double benefit of enabling faster development of variant-specific vaccines and easy nasal… August 15, 2022 14:41 IST
Bharat Biotech expects DGCI’s nod for intranasal COVID-19 vaccine this month Ella said the firm completed clinical trials of the nasal vaccine with about 4,000 volunteers and there is no single… August 2, 2022 13:40 IST
ExcellGene partners with Bharat Biotech, CEPI and Sydney University to develop ‘variant-proof’ COVID-19 vaccine On Tuesday, ExcellGene informed that it will produce complex chimeric Spike antigens using its engineered CHOExpress-cell-based technology. July 26, 2022 19:24 IST
Germany to recognise Covaxin for travel from June 1 German Ambassador to India and Bhutan, Walter J Lindner on Thursday said the government of the European nation will start… Updated: May 26, 2022 14:49 IST
CEPI to provide up to $19.3 m to Bharat Biotech, others for development of ‘variant-proof’ Covid vaccine CEPI will provide funding of up to $19.3 million to support the development of a ‘variant-proof’ SARS-CoV-2 vaccine candidate to… May 11, 2022 08:09 IST
Bharat Biotech must address WHO’s Covaxin suspension to avoid EUL cancellation, says MEA In a communication to Dr V K Paul, the convenor of a key empowered group on Covid vaccination, on Tuesday… April 28, 2022 19:56 IST
Indian student returns from US with $40,000 debt after 10K job rejections: ‘I lost four years of my life’
Dubai, Abu Dhabi Iran War LIVE: Mojtaba demands closure of Gulf US bases, threatens to open ‘other fronts’ in clash
US Iran War LIVE: US will make money, says Trump as oil tops $100 per barrel; PM Modi calls Iranian president, flags Indians’ safety and energy flow